MedPath

TEVA-AMBRISENTAN

TEVA-AMBRISENTAN

Discontinued
DIN Number

02536242

Drug Class

Human

Market Date

N/A

Company
HC

teva canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02536242
AIG Number0152452002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C02KX02 AMBRISENTAN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification48:48.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

AMBRISENTANActive
Strength: 10 MG
Monograph: AMBRISENTAN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.